Characterization of HIV isolates arising after prolonged zidovudine therapy

Douglas L. Mayers, Francine E. McCutchan, Eric E. Sanders-Buell, Linda I. Merritt, Sonya Dilworth, Arnold K. Fowler, Christopher A. Marks, Nancy M. Ruiz, Douglas D. Richman, Chester R. Roberts, Donald S. Burke

Research output: Contribution to journalArticle

Abstract

Human immunodeficiency virus type 1 (HIV-1) was isolated from five patients with late-stage disease treated with zidovudine (ZDV) for more than 1 year. Peripheral blood mononuclear cells (PBMCs) were used for all virus isolations and to assay for drug resistance. The isolates exhibited a 10- to 100-fold decrease in ZDV susceptibility compared to pretreatment isolates. Multiple clones of a 618 bp segment of the HIV reverse transcriptase gene encompassing codons 60-250 were sequenced for each isolate. The association of alterations at codons Asp67 → Asn, Lys70 → Arg, Thr215 → Phe or Tyr, and Lys219 → Gln with ZDV resistance has been previously noted (ref. 5). In this study, the most frequent alteration was Thr215 → Tyr although genotypic mixtures of Thr/Tyr and Phe/Tyr were also observed. One isolate with a Tyr215 alteration and unaltered codons at 67, 70, and 219 had high-level ZDV resistance. Alterations at codons 67, 70, and 219 did not appear to increase resistance when seen in combination with Tyr215. Virus isolates obtained from each patient by cultivation with either 0 or 4 μM ZDV were compared and found to have similar alterations at codons 67, 70, 215, and 219, although one instance of apparent in vitro selection for Tyr215 over Phe215 was observed. Assays using PBMCs for virus propagation will permit susceptibility testing of HIV isolates from most patients on antiretroviral drugs to investigate the clinical significance of drug resistance.

Original languageEnglish (US)
Pages (from-to)749-759
Number of pages11
JournalJournal of Acquired Immune Deficiency Syndromes
Volume5
Issue number8
StatePublished - 1992
Externally publishedYes

Fingerprint

Zidovudine
Codon
HIV
Viruses
Drug Resistance
Blood Cells
HIV Reverse Transcriptase
Therapeutics
HIV-1
Clone Cells
Pharmaceutical Preparations
Genes

Keywords

  • DNA sequence
  • Reverse transcriptase
  • Susceptibility assay
  • Zidovudine resistance

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Virology
  • Immunology and Allergy

Cite this

Mayers, D. L., McCutchan, F. E., Sanders-Buell, E. E., Merritt, L. I., Dilworth, S., Fowler, A. K., ... Burke, D. S. (1992). Characterization of HIV isolates arising after prolonged zidovudine therapy. Journal of Acquired Immune Deficiency Syndromes, 5(8), 749-759.

Characterization of HIV isolates arising after prolonged zidovudine therapy. / Mayers, Douglas L.; McCutchan, Francine E.; Sanders-Buell, Eric E.; Merritt, Linda I.; Dilworth, Sonya; Fowler, Arnold K.; Marks, Christopher A.; Ruiz, Nancy M.; Richman, Douglas D.; Roberts, Chester R.; Burke, Donald S.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 5, No. 8, 1992, p. 749-759.

Research output: Contribution to journalArticle

Mayers, DL, McCutchan, FE, Sanders-Buell, EE, Merritt, LI, Dilworth, S, Fowler, AK, Marks, CA, Ruiz, NM, Richman, DD, Roberts, CR & Burke, DS 1992, 'Characterization of HIV isolates arising after prolonged zidovudine therapy', Journal of Acquired Immune Deficiency Syndromes, vol. 5, no. 8, pp. 749-759.
Mayers DL, McCutchan FE, Sanders-Buell EE, Merritt LI, Dilworth S, Fowler AK et al. Characterization of HIV isolates arising after prolonged zidovudine therapy. Journal of Acquired Immune Deficiency Syndromes. 1992;5(8):749-759.
Mayers, Douglas L. ; McCutchan, Francine E. ; Sanders-Buell, Eric E. ; Merritt, Linda I. ; Dilworth, Sonya ; Fowler, Arnold K. ; Marks, Christopher A. ; Ruiz, Nancy M. ; Richman, Douglas D. ; Roberts, Chester R. ; Burke, Donald S. / Characterization of HIV isolates arising after prolonged zidovudine therapy. In: Journal of Acquired Immune Deficiency Syndromes. 1992 ; Vol. 5, No. 8. pp. 749-759.
@article{6a49caf2e7a84e85832da5f33d60f05d,
title = "Characterization of HIV isolates arising after prolonged zidovudine therapy",
abstract = "Human immunodeficiency virus type 1 (HIV-1) was isolated from five patients with late-stage disease treated with zidovudine (ZDV) for more than 1 year. Peripheral blood mononuclear cells (PBMCs) were used for all virus isolations and to assay for drug resistance. The isolates exhibited a 10- to 100-fold decrease in ZDV susceptibility compared to pretreatment isolates. Multiple clones of a 618 bp segment of the HIV reverse transcriptase gene encompassing codons 60-250 were sequenced for each isolate. The association of alterations at codons Asp67 → Asn, Lys70 → Arg, Thr215 → Phe or Tyr, and Lys219 → Gln with ZDV resistance has been previously noted (ref. 5). In this study, the most frequent alteration was Thr215 → Tyr although genotypic mixtures of Thr/Tyr and Phe/Tyr were also observed. One isolate with a Tyr215 alteration and unaltered codons at 67, 70, and 219 had high-level ZDV resistance. Alterations at codons 67, 70, and 219 did not appear to increase resistance when seen in combination with Tyr215. Virus isolates obtained from each patient by cultivation with either 0 or 4 μM ZDV were compared and found to have similar alterations at codons 67, 70, 215, and 219, although one instance of apparent in vitro selection for Tyr215 over Phe215 was observed. Assays using PBMCs for virus propagation will permit susceptibility testing of HIV isolates from most patients on antiretroviral drugs to investigate the clinical significance of drug resistance.",
keywords = "DNA sequence, Reverse transcriptase, Susceptibility assay, Zidovudine resistance",
author = "Mayers, {Douglas L.} and McCutchan, {Francine E.} and Sanders-Buell, {Eric E.} and Merritt, {Linda I.} and Sonya Dilworth and Fowler, {Arnold K.} and Marks, {Christopher A.} and Ruiz, {Nancy M.} and Richman, {Douglas D.} and Roberts, {Chester R.} and Burke, {Donald S.}",
year = "1992",
language = "English (US)",
volume = "5",
pages = "749--759",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Characterization of HIV isolates arising after prolonged zidovudine therapy

AU - Mayers, Douglas L.

AU - McCutchan, Francine E.

AU - Sanders-Buell, Eric E.

AU - Merritt, Linda I.

AU - Dilworth, Sonya

AU - Fowler, Arnold K.

AU - Marks, Christopher A.

AU - Ruiz, Nancy M.

AU - Richman, Douglas D.

AU - Roberts, Chester R.

AU - Burke, Donald S.

PY - 1992

Y1 - 1992

N2 - Human immunodeficiency virus type 1 (HIV-1) was isolated from five patients with late-stage disease treated with zidovudine (ZDV) for more than 1 year. Peripheral blood mononuclear cells (PBMCs) were used for all virus isolations and to assay for drug resistance. The isolates exhibited a 10- to 100-fold decrease in ZDV susceptibility compared to pretreatment isolates. Multiple clones of a 618 bp segment of the HIV reverse transcriptase gene encompassing codons 60-250 were sequenced for each isolate. The association of alterations at codons Asp67 → Asn, Lys70 → Arg, Thr215 → Phe or Tyr, and Lys219 → Gln with ZDV resistance has been previously noted (ref. 5). In this study, the most frequent alteration was Thr215 → Tyr although genotypic mixtures of Thr/Tyr and Phe/Tyr were also observed. One isolate with a Tyr215 alteration and unaltered codons at 67, 70, and 219 had high-level ZDV resistance. Alterations at codons 67, 70, and 219 did not appear to increase resistance when seen in combination with Tyr215. Virus isolates obtained from each patient by cultivation with either 0 or 4 μM ZDV were compared and found to have similar alterations at codons 67, 70, 215, and 219, although one instance of apparent in vitro selection for Tyr215 over Phe215 was observed. Assays using PBMCs for virus propagation will permit susceptibility testing of HIV isolates from most patients on antiretroviral drugs to investigate the clinical significance of drug resistance.

AB - Human immunodeficiency virus type 1 (HIV-1) was isolated from five patients with late-stage disease treated with zidovudine (ZDV) for more than 1 year. Peripheral blood mononuclear cells (PBMCs) were used for all virus isolations and to assay for drug resistance. The isolates exhibited a 10- to 100-fold decrease in ZDV susceptibility compared to pretreatment isolates. Multiple clones of a 618 bp segment of the HIV reverse transcriptase gene encompassing codons 60-250 were sequenced for each isolate. The association of alterations at codons Asp67 → Asn, Lys70 → Arg, Thr215 → Phe or Tyr, and Lys219 → Gln with ZDV resistance has been previously noted (ref. 5). In this study, the most frequent alteration was Thr215 → Tyr although genotypic mixtures of Thr/Tyr and Phe/Tyr were also observed. One isolate with a Tyr215 alteration and unaltered codons at 67, 70, and 219 had high-level ZDV resistance. Alterations at codons 67, 70, and 219 did not appear to increase resistance when seen in combination with Tyr215. Virus isolates obtained from each patient by cultivation with either 0 or 4 μM ZDV were compared and found to have similar alterations at codons 67, 70, 215, and 219, although one instance of apparent in vitro selection for Tyr215 over Phe215 was observed. Assays using PBMCs for virus propagation will permit susceptibility testing of HIV isolates from most patients on antiretroviral drugs to investigate the clinical significance of drug resistance.

KW - DNA sequence

KW - Reverse transcriptase

KW - Susceptibility assay

KW - Zidovudine resistance

UR - http://www.scopus.com/inward/record.url?scp=0026655856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026655856&partnerID=8YFLogxK

M3 - Article

C2 - 1381438

AN - SCOPUS:0026655856

VL - 5

SP - 749

EP - 759

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 8

ER -